articleTop 1% cited

Dexamethasone Intravitreal Implant for Noninfectious Intermediate or Posterior Uveitis

Archives of Ophthalmology · 2011 · Vol. 129(5) · pp. 144–145

Careen Y. Lowder✉(Cleveland Eye Clinic)

Abstract

In patients with noninfectious intermediate or posterior uveitis, a single DEX implant significantly improved intraocular inflammation and visual acuity persisting for 6 months. Application to Clinical Practice Dexamethasone intravitreal implant may be used safely and effectively for treatment of intermediate and posterior uveitis. Trial Registration clinicaltrials.gov Identifier: NCT00333814.

Ocular Diseases and Behçet’s Syndrome Retinal Diseases and Treatments Retinal and Optic ConditionsImplantMedicineDexamethasoneUveitisOphthalmologyIntraocular pressureVisual acuitySurgeryInternal medicine

MeSH terms

AdultCataractDexamethasoneDouble-Blind MethodDrug ImplantsFemaleGlucocorticoidsHumansIntraocular PressureMaleMiddle AgedProspective StudiesVisual AcuityVitreous BodyEye Infections

Citations

655

FWCI

40.65

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Dexamethasone Intravitreal Implant for Noninfectious Intermediate or Posterior Uveitis